MarketsandMarkets is a global market research and consulting company that provides business insights and market intelligence to help organizations make informed decisions.

MarketsandMarkets

Poten & Partners provides insights into the international oil, gas, and shipping markets. The firm offers services including ship and commodity brokerage, research, business intelligence, consulting, commercial advisory, and business training.

Poten & Partners

Chief Revenue Officer Talk Series

IndustryNews By Markets And Markets

MarketsandMarkets-Healthcare Industry

MarketsandMarkets-ICT

MarketsandMarkets™ - Food, Beverage & Agriculture

MarketsandMarkets-Chemicals

DisruptionDialogues

MarketsandMarkets-Semiconductor

MarketsandMarkets™ - Aerospace & Defense Research

MarketsandMarkets - Automotive & Transportation

MarketsandMarkets Revenue Impact Talks

Founded in 2009, MarketsandMarkets recognized uncharted business potentials within disruptive trends, forecasting a surge of $25 trillion in new B2B revenues by 2030. Over the years, we've collaborated with 10,000+ companies, generating $140+ billion in revenue impact. We evolved from a market research publisher to a growth-enabling firm, fostering a growth mindset among our 1500+ employees through our "GIVE growth" culture. Our exceptional standing was affirmed when Forbes recognized us as one of America's Top Management Consulting Firms, highlighting our pioneering AI-driven platform, the Knowledge Store, designed exclusively for growth-minded executives.

Zodius Capital

FTV Capital

MarketsandMarkets™

The turn of the decade has laid the groundwork for an unprecedented range of revolutionary advancements and technological innovations, propelling us toward an imminent transition to a new dawn across the entire spectrum of #modernmedicine .
 
Given such exciting times, our global healthcare leadership team hosted the MarketsandMarkets 'Healthcare 5.0 Roundtable' last night in Vienna, coinciding with #ECR2024, whose theme for this year was #NextGenerationRadiology!

Our exclusive networking evening saw wonderful participation from 20+ eminent thought leaders, technical experts and industry veterans to delve into the future of #radiology and it’s subsequent impact on #PrecisionMedicine!

Our aim was to facilitate discourse on a plethora of topics spanning the latest developments across the medical landscape such as the roadmap to adoption for #integrateddiagnostics and the ongoing incorporation and comprehensive impact of #AI in the near future. 
  
It was an absolute pleasure to set up a space for collaborative and thought-provoking dialogue from unique vantage points across the value chain. A sincere note of thanks to the esteemed group of leaders who made the evening a huge success!
 
Dr. Anjum M. Ahmed (MBBS, MBA, MIS) | Ankur Sharma | David Hilderbrand | Dr Amine Korchi | Julie Sufana | Vittorio Sportelli, Pharm.D. | Yael Misrahi | Jan Beger | Murat Akturk | Brandon B. Suh | Antoine Disset, PhD | Erik R. Ranschaert, MD, PhD | Robert Wagner | Mayank MOHUN | Maria Proud , MHA | Michael Coulter | Thomas Juhl Olesen | Sinan Batman | Siddharth Saha | Farhan Hussain | Siddharth Shah

#radiology #medicine #diagnostics #healthcare 

The ImmunoBio Series 2024 - UK Edition is just around the corner, and we're proud to introduce our sponsor partners: Volition | Predicine | Ultivue | Proteome Sciences plc | GemPharmatech | EpigenDx, Inc. | ANGLE | Veracyte, Inc. | Canopy Biosciences | Ground Truth Labs | ViroCell Biologics | ICON plc | Akoya Biosciences, Inc. | Randox | Agilent Technologies | Charles River Laboratories | Rules-Based Medicine a Q² Solutions Company | Novogene Europe | Sino Biological, Inc. | Antibody Analytics of this insightful event. Happening on 07th-08th March at Park Plaza Victoria London, the series features two co-located conferences – the 5th Annual Biomarker and Companion Diagnostics Conference and the 8th Annual Next Gen Immuno-Oncology Conference.

Join us in expressing gratitude to our sponsors for their unwavering commitment to advancing research and driving progress in these critical areas.

Know more: https://lnkd.in/dngS_Gg6

#biomarker #personalizedmedicine #biomarkervalidation #companiondiagnostics #healthcare #pharma #healthcaretechnology #marketsandmarkets #ConferenceRegistration #oncology #oncologyresearch #cancer #medicine #oncologia #immunooncology #pharmaceutical  

Exciting Announcement! We are thrilled to offer complimentary delegate passes for the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, happening on 21st-22nd March 2024 at Millennium Gloucester Hotel London Kensington.

Don't miss this incredible opportunity to be a part of cutting-edge discussions in Urology and gynaecology. Network with industry leaders, learn from experts and stay ahead of the curve in minimally invasive surgery.

Secure your spot at this transformative event. Limited seats are available, so act fast! Join us as we push the boundaries of surgical innovation. See you there!

#MISConference #FreeDelegatePass #surgicalinnovation #MIS2024 #roboticsurgery  #gynecology  #urology  #minimallyinvasivesurgery  #conferences #healthcare #marketsandmarkets #laproscopy #endoscopy 

Exciting News! We're thrilled to announce the Final Call for our esteemed speakers, sponsor partners, and attendees for the forthcoming MarketsandMarkets ImmunoBio Series 2024 - UK Edition! Join us on 07th - 8th March 2024 at Park Plaza Victoria London by Radisson, 239 Vauxhall Bridge Rd, Pimlico, London SW1V 1EQ, UK.

🎤 This series features two co-located events:
1️⃣ 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference
2️⃣ 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Don't miss this opportunity to be part of groundbreaking discussions and advancements in the field of ImmunoBio. Save the dates and be part of the future of healthcare!

#biomarker #personalizedmedicine #biomarkervalidation #companiondiagnostics #healthcare #pharma #healthcaretechnology #marketsandmarkets #ConferenceRegistration #oncology #oncologyresearch #cancer #medicine #oncologia #immunooncology #healthcare #therapy #pharmaceutical 

Metric
Company Name	MarketsandMarkets	Poten & Partners
Symbol
MSH ID	COM:MARKETSANDMARKETS	COM:POTEN
Market	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Commercial & Professional Services
Industry	Market Research and Consulting	Energy and Shipping
Country	IN	US
Stage
Employee Count	1.80K	101
Website	marketsandmarkets.com	poten.com
LinkedIn	marketsandmarkets
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		4.26K
Web Traffic Growth		0.60
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	53.30
28-Day Growth Score	23.44
90-Day Growth Score	80.11
365-Day Growth Score	81.17

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MARKETSANDMARKETS

MarketsandMarkets

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue